A collaborative approach to funding a novel process that uses gravity to separate biochemicals.

Features - May 2019

In 2017 Ben Dolman, a PhD student at The University of Manchester, was named a finalist in Nouryon’s Imagine Chemistry collaborative innovation program for his novel process that uses gravity to separate biochemicals. Two years later, Holiferm, the startup he co-founded together with James Winterburn, is commercialising the technology, which they co-invented at the university, thanks in part to funding from Icos Capital’s ICF III fund. Nouryon is a strategic investor in this fund.

"Current methods are inefficient because of production and processing difficulties, making Holiferm’s production technology a major breakthrough."

“The technology we provide allows for a more cost-efficient production of bio-based materials, including surfactants. The technology uses gravity to separate biochemicals as they are produced, requiring less energy and no solvents, and increasing the output of existing production plants up to four times,” says Dolman. “The financial resources and business support provided by Icos will enable us to rapidly accelerate our business and technical scale-up.”

The technology has been demonstrated at pilot scale with sophorolipids – biosurfactants used in detergents and personal care products. Holiferm now plans to scale up the technology to pre-industrial scale and demonstrate the technology with other bioproducts.

Marco Waas, Director RD&I Industrial Chemicals at Nouryon and member of Icos’s Fund supervisory board, adds: “This is a nice example of our collaborative innovation approach. Holiferm’s technology is a potential breakthrough in process efficiency for products like biosurfactants. The Icos investment will enable them to scale-up their activities to meet the marketplace’s need for green chemicals.”

ICF III is a €50 million collaborative venture capital fund managed by Icos in partnership with Nouryon, Royal Cosun and Bühler Group. ICF III invests in early stage chemical and cleantech startups. It is the fund’s third investment and it plans 9-12 more investments. Other investments of Icos Capital includes Photanol, which is working with Nouryon on a technology to make chemicals from CO2 and sunlight.

Related vacancies

See all vacancies

A global specialty chemicals leader.

Markets and consumers worldwide rely on our essential solutions to manufacture everyday products, such as personal care, cleaning goods, paints and coatings, agriculture and food, pharmaceuticals, and building products. Furthermore, the dedication of more than 7,900 employees with a shared commitment to our customers, business growth, safety, sustainability and innovation has resulted in a consistently strong financial performance. We operate in over 80 countries around the world with a portfolio of industry-leading brands.